Delivery Order SPE2DB20D3303-SPE2DB24FA2EG
Award Date
8/19/24
Potential Completion Date
8/20/24
Potential Value
$5.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract. The $2,073.93 firm fixed price contract is for the delivery of 4,565,698,072 tablets of the pharmaceutical drug febuxostat 40 mg. The contract has a period of performance through September 6, 2024 and does not utilize a set-aside designation. As a major pharmaceutical distributor,...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,976.80 firm fixed-price delivery order is for the supply of the drug febuxostat 80 mg tablets. The contract has an ultimate completion date of December 9, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,290.59, is a Firm Fixed Price Delivery Order for the provision of Febuxostat 40 mg tablets. The award has an ultimate completion date of November 7, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of febuxostat 40 mg tablets. The contract is a delivery order with a firm fixed price of $2,540.62 and a completion date of September 3, 2024. It is not designated as a set-aside contract. AmerisourceBergen, through its Corporate Office division, will supply these pharmaceutical products to support military treatment facilities and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $3,490.30 firm-fixed-price contract is for the delivery of 4565787514 Febuxostat 80 mg tablets, which are a prescription medication. The contract has an ultimate completion date of September 13, 2024 and does not use a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,913.99 Firm Fixed Price Delivery Order contract is for the supply of febuxostat 40 mg tablets. The contract is not set aside and is a child award under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical through November 2026. This...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $2,255.44 to provide the drug Febuxostat 40 mg Tablet 30s. The contract has an ultimate completion date of February 14, 2024 and was awarded on February 13, 2024 by the Defense Logistics Agency (DLA), a defense agency. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,277.66, is for the delivery of 4562280454 ! FEBUXOSTAT 40 MG TABLET 30S. It is a firm fixed-price delivery order with a completion date of September 25, 2023. The contract is not associated with a set-aside designation. Amerisourcebergen Drug Corp is a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $8,280.57 fixed-price contract is for the supply of febuxostat 40 mg tablets, a medication used to treat gout. The contract has an ultimate completion date of July 26, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Febuxostat 80 mg tablets. The $1,328.20 firm fixed-price award has a period of performance through July 2024. Amerisourcebergen provides a wide range of essential pharmaceutical and medical products to federal agencies and healthcare programs, including military treatment facilities and veterans' hospitals. This delivery order is part of a...